These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15936249)

  • 1. Treatment with oral bromelain decreases colonic inflammation in the IL-10-deficient murine model of inflammatory bowel disease.
    Hale LP; Greer PK; Trinh CT; Gottfried MR
    Clin Immunol; 2005 Aug; 116(2):135-42. PubMed ID: 15936249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary supplementation with fresh pineapple juice decreases inflammation and colonic neoplasia in IL-10-deficient mice with colitis.
    Hale LP; Chichlowski M; Trinh CT; Greer PK
    Inflamm Bowel Dis; 2010 Dec; 16(12):2012-21. PubMed ID: 20848493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral immunogenicity of the plant proteinase bromelain.
    Hale LP; Fitzhugh DJ; Staats HF
    Int Immunopharmacol; 2006 Dec; 6(13-14):2038-46. PubMed ID: 17161360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteolytic activity and immunogenicity of oral bromelain within the gastrointestinal tract of mice.
    Hale LP
    Int Immunopharmacol; 2004 Feb; 4(2):255-64. PubMed ID: 14996417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Lipoxygenase-derived lipid mediators are not required for the development of NSAID-induced inflammatory bowel disease in IL-10-/- mice.
    Narushima S; DiMeo D; Tian J; Zhang J; Liu D; Berg DJ
    Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G477-88. PubMed ID: 18048478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of enterocolitis in the piroxicam-accelerated interleukin-10 knock out mouse--a model mimicking inflammatory bowel disease.
    Holgersen K; Kvist PH; Markholst H; Hansen AK; Holm TL
    J Crohns Colitis; 2014 Feb; 8(2):147-60. PubMed ID: 23994255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orally administered allyl sulfides from garlic ameliorate murine colitis.
    Fasolino I; Izzo AA; Clavel T; Romano B; Haller D; Borrelli F
    Mol Nutr Food Res; 2015 Mar; 59(3):434-42. PubMed ID: 25488545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of triptolide on interleukin-10 gene-deficient mice with colitis.
    Wei X; Gong J; Zhu J; Niu L; Zhu W; Li N; Li J
    Int Immunopharmacol; 2008 Dec; 8(13-14):1808-12. PubMed ID: 18804190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive validity and immune cell involvement in the pathogenesis of piroxicam-accelerated colitis in interleukin-10 knockout mice.
    Holgersen K; Kvist PH; Hansen AK; Holm TL
    Int Immunopharmacol; 2014 Jul; 21(1):137-47. PubMed ID: 24797915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromelain limits airway inflammation in an ovalbumin-induced murine model of established asthma.
    Secor ER; Shah SJ; Guernsey LA; Schramm CM; Thrall RS
    Altern Ther Health Med; 2012; 18(5):9-17. PubMed ID: 22894886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human adipose-derived stem cells attenuate inflammatory bowel disease in IL-10 knockout mice.
    Jung WY; Kang JH; Kim KG; Kim HS; Jang BI; Park YH; Song IH
    Tissue Cell; 2015 Feb; 47(1):86-93. PubMed ID: 25544730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of CXCL12/CXCR4 axis ameliorates murine experimental colitis.
    Mikami S; Nakase H; Yamamoto S; Takeda Y; Yoshino T; Kasahara K; Ueno S; Uza N; Oishi S; Fujii N; Nagasawa T; Chiba T
    J Pharmacol Exp Ther; 2008 Nov; 327(2):383-92. PubMed ID: 18716065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bromelain treatment decreases secretion of pro-inflammatory cytokines and chemokines by colon biopsies in vitro.
    Onken JE; Greer PK; Calingaert B; Hale LP
    Clin Immunol; 2008 Mar; 126(3):345-52. PubMed ID: 18160345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein.
    Foligne B; Dessein R; Marceau M; Poiret S; Chamaillard M; Pot B; Simonet M; Daniel C
    Gastroenterology; 2007 Sep; 133(3):862-74. PubMed ID: 17678918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of experimental mouse models of inflammatory bowel disease.
    Oh SY; Cho KA; Kang JL; Kim KH; Woo SY
    Int J Mol Med; 2014 Feb; 33(2):333-40. PubMed ID: 24285285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application and relevance of ex vivo culture systems for assessment of IBD treatment in murine models of colitis.
    Fritsch Fredin M; Vidal A; Utkovic H; Götlind YY; Willén R; Jansson L; Hultgren Hörnquist E; Melgar S
    Pharmacol Res; 2008; 58(3-4):222-31. PubMed ID: 18812224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a novel IL-10 deficient cell transfer model for colitis.
    Ikenoue Y; Tagami T; Murata M
    Int Immunopharmacol; 2005 Jun; 5(6):993-1006. PubMed ID: 15829415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of drugs used in the treatment of IBD and combinations thereof in acute DSS-induced colitis in mice.
    Sann H; Erichsen Jv; Hessmann M; Pahl A; Hoffmeyer A
    Life Sci; 2013 Apr; 92(12):708-18. PubMed ID: 23399699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
    Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
    Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The opioid antagonist naltrexone improves murine inflammatory bowel disease.
    Matters GL; Harms JF; McGovern C; Fitzpatrick L; Parikh A; Nilo N; Smith JP
    J Immunotoxicol; 2008 Apr; 5(2):179-87. PubMed ID: 18569389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.